Patent ID: 9675664
Date: 2017-06-13
CPC Classifications: A61K,A61P,C07K,G01N

Claim:
1. A method of treating a pre-eclampsia (PE)-type disorder in a subject in need of such treatment comprising administering to the subject a pharmaceutical composition containing a therapeutically effective amount of a transthyretin (TTR) polypeptide in admixture with a pharmaceutically acceptable vehicle wherein said TTR polypeptide is selected from the group consisting of TTR (Uniprot:P02766), TTR fragment Ser 137 to Cys, glutamic acid residue Glu 122 to Cys, threonine residue T 139 to Methionine, or a TTR fragment selected from the group consisting of SEQ ID NOs:1, 2, and 3.